Search Results

Association between Drug and Vaccine Use and Acute Immune Thrombocytopenia in Childhood: A Case-Control Study in Italy

Authors: Bertuola, Federica; Morando, Carla; Menniti-Ippolito, Francesca; >Roberto Da Cas,; Capuano, Annalisa; Perilongo, Giorgio; >Liviana Da Dalt,

Source: Drug Safety, Volume 33, Number 1, 1 January 2010 , pp. 65-72(8)

Publisher: Adis International

Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design

Authors: Madan, Ravi A; Mohebtash, Mahsa; Schlom, Jeffrey; Gulley, James L

Source: Expert Opinion on Biological Therapy, Volume 10, Number 1, January 2010 , pp. 19-28(10)

Publisher: Informa Healthcare

Intracellular delivery of major histocompatibility complex class I-binding epitopes: dendritic cells loaded and matured with cationic peptide/poly(I:C) complexes efficiently activate T cells

Authors: Haenssle, Holger A.; Riedl, Petra; Buhl, Timo; Schardt, Anke; Rosenberger, Albert; Schön, Michael P.; Schirmbeck, Reinhold

Source: Experimental Dermatology, Volume 19, Number 1, January 2010 , pp. 19-28(10)

Publisher: Blackwell Publishing

Evaluation of a hepatitis B vaccination program in Taiwan: impact on hepatocellular carcinoma development

Author: Chemin, Isabelle

Source: Future Oncology, Volume 6, Number 1, January 2010 , pp. 21-23(3)

Publisher: Future Medicine

Temporal perspective and parental intention to accept the human papillomavirus vaccination for their daughter

Authors: Morison, Linda A.; Cozzolino, Philip J.; Orbell, Sheina

Source: British Journal of Health Psychology, Volume 15, Number 1, February 2010 , pp. 151-165(15)

Publisher: British Psychological Society

Editorial [Hot topic: New Generation Cancer Vaccines: From Tumor Immunology to Clinical Applications (Executive Editor: Simone Mocellin)]

Author: Mocellin, Simone

Source: Current Pharmaceutical Design, Volume 16, Number 3, January 2010 , pp. 253-254(2)

Publisher: Bentham Science Publishers

Circumventing Immune Tolerance Through Epigenetic Modification

Authors: Dubovsky, Jason A.; Villagra, Alejandro; Powers, John J.; Wang, Hong-Wei; Pinilla-Ibarz, Javier; Sotomayor, Eduardo M.

Source: Current Pharmaceutical Design, Volume 16, Number 3, January 2010 , pp. 268-276(9)

Publisher: Bentham Science Publishers

Metabolic Immune Restraints: Implications for Anticancer Vaccines

Author: Mocellin, Simone

Source: Current Pharmaceutical Design, Volume 16, Number 3, January 2010 , pp. 277-291(15)

Publisher: Bentham Science Publishers

Cancer Vaccines: Emphasis on Pediatric Cancers

Authors: Guinipero, Terri; Finn, Olivera J.

Source: Current Pharmaceutical Design, Volume 16, Number 3, January 2010 , pp. 292-299(8)

Publisher: Bentham Science Publishers

Topical resiquimod: a promising adjuvant for vaccine development?

Authors: Igartua, Manoli; Pedraz, José Luís

Source: Expert Review of Vaccines, Volume 9, Number 1, January 2010 , pp. 23-27(5)

Publisher: Expert Reviews

Prophylactic HPV vaccines: the Finnish perspective

Author: Syrjänen, Kari J

Source: Expert Review of Vaccines, Volume 9, Number 1, January 2010 , pp. 45-57(13)

Publisher: Expert Reviews

Mechanisms of T-cell inhibition: implications for cancer immunotherapy

Authors: Mittendorf, Elizabeth A; Sharma, Padmanee

Source: Expert Review of Vaccines, Volume 9, Number 1, January 2010 , pp. 89-105(17)

Publisher: Expert Reviews

Recent Advances of Dendritic Cells (DCs)-Based Immunotherapy for Malignant Gliomas

Authors: Cho, Der-Yang; Lin, Shinn-Zong; Yang, Wen-Kuang; Hsu, Den-Mei; Lee, Han-Chung; Lee, Wen-Yeun; Liu, Shih-Ping

Source: Cell Transplantation, Volume 18, Number 9, 2009 , pp. 977-983(7)

Publisher: Cognizant Communication Corporation

High HPV vaccine acceptance despite low awareness among Swedish upper secondary school students

Authors: Gottvall, Maria; Larsson, Margareta; Höglund, Anna T.; Tydén, Tanja

Source: The European Journal of Contraception and Reproductive Health Care, Volume 14, Number 6, December 2009 , pp. 399-405(7)

Publisher: Informa Healthcare

Prioritization of cancer antigens: keeping the target in sight

Authors: Lang, Joshua M; Andrei, Adin-Cristian; McNeel, Douglas G

Source: Expert Review of Vaccines, Volume 8, Number 12, December 2009 , pp. 1657-1661(5)

Publisher: Expert Reviews

Currently approved prophylactic HPV vaccines

Author: Harper, Diane M

Source: Expert Review of Vaccines, Volume 8, Number 12, December 2009 , pp. 1663-1679(17)

Publisher: Expert Reviews

Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation

Authors: Garetto, Stefano; Sizzano, Federico; Brusa, Davide; Tizzani, Alessandro; Malavasi, Fabio; Matera, Lina

Source: Cytotherapy, Volume 11, Number 8, November 2009 , pp. 1090-1100(11)

Publisher: Informa Healthcare

T-cell epitope analogues from carcinoembryonic antigen for vaccination against cancer: WO2009002418

Author: Hallermalm, Kristian

Source: Expert Opinion on Therapeutic Patents, Volume 19, Number 11, November 2009 , pp. 1635-1637(3)

Publisher: Informa Healthcare

CpG Oligodeoxynucleotides as TLR9 Agonists: Therapeutic Applications in Cancer

Authors: Murad, Yanal M.; Clay, Timothy M.

Source: BioDrugs, Volume 23, Number 6, 1 December 2009 , pp. 361-375(15)

Publisher: Adis International

Recent Advances in Improving Sub-Unit Vaccine Efficacy Using Cytokines as more Specific Immune Inducing Adjuvants

Authors: Di Cesare, Sebastian; Abourbih, Daniel; Belfort, Rubens N.; Petruccelli, Luca A.; Burnier Jr., Miguel N.

Source: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Cu, Volume 8, Number 4, December 2009 , pp. 357-365(9)

Publisher: Bentham Science Publishers